© BusinessWire
30.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare builds on a century of innovation to shape the future of radiology at RSNA 2025
News Preview
At this year’s Radiological Society of North America’s (RSNA) 2025 Annual Meeting, GE HealthCare (Nasdaq: GEHC) will showcase a wave of significant innovations grounded by its legacy and deep, global commitment to advancing precision care. For more than a century, GE HealthCare has stood at the intersection of medicine and technology—helping clini...
Themefolio
Profiler
Peergroup
© BusinessWire
30.11.2025
GEHC
LISTED
NASDAQ
GE HealthCare unveils next-generation SIGNA MRI technology, aiming to boost efficiency, enhance patient experience, and advance sustainability
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI technology. Unveiled at the Radiological Society of North America’s 2025 Annual Meeting, these differentiated solutions are part of a wave of new GE HealthCare innovations aimed at tack...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.11.2025
RDNT
LISTED
NASDAQ
DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI Solutions at RSNA 2025, Advancing a New Standard of AI-Powered Care
News Preview
DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI Solutions at RSNA 2025, Advancing a New Standard of AI-Powered Care...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Newsfile
29.11.2025
DOSE
LISTED
CSE
Rapid Dose Announces Extension to Promissory Notes
News Preview
Burlington, Ontario--(Newsfile Corp. - November 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it intends to extend the maturity date of its outstanding secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing") which closed in 2023. T...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
29.11.2025
RKV
LISTED
TSX
Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program
News Preview
VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, announces that further to its news release dated June 30, 2025, and in accordance with the terms of a debenture in...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.11.2025
AGN
LISTED
CSE
Algernon Closes Second Tranche of Private Placement Financing
News Preview
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.11.2025
PCRX
LISTED
TSX
Pharmacorp Rx Inc. Reports Q3 2025 Financial Results
News Preview
SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a growing national platform for pharmacist-led community pharmacy ownership, today reported its financial results for the three and nine months ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.11.2025
PCRX
LISTED
TSX
PharmaCorp Announces Executive Transition and New Director of Business Development
News Preview
SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) today announced an executive transition in which Paul Dale has been appointed President and Chief Operating Officer, effective December 1, 2025, as Calvin LeRoux steps aside from the President role and assumes a one-year...
Themefolio
Profiler
Peergroup
© BusinessWire
28.11.2025
MOH
LISTED
NYSE
Molina Healthcare 96 Hour Deadline Alert: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Molina Healthcare, Inc. - MOH
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 2, 2025 to file lead plaintiff applications in a securities class action lawsuit against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH), if they purchased or otherwise a...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.11.2025
AYUR
LISTED
CSE
AYURCANN REPORTS Q1 2026 SALES OF $14,638,697
News Preview
Toronto, Ontario, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”) is excited to announce its financial and operational results for the three months ended September 30, 2025, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2025
THQ
LISTED
NYSE
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS
News Preview
PHILADELPHIA, Nov. 28, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI, THQ), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on November 28, 2025, on a per share basis to all shareholders of record as of November 21, 2025 (ex-dividend date Nov...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
28.11.2025
MIR
LISTED
TSX
MedMira Reports FY2025 Fourth Quarter and Year End Financial Results
News Preview
HALIFAX, NOVA SCOTIA / ACCESS Newswire / November 28, 2025 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the financial year ended July 31, 2025.Corporate updateIn FY2025, MedMira launched its recently Health Canada approved Multiplo® Rapid TP/HIV Test (Multiplo® TP/HIV) and its latest generation of its R...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
28.11.2025
ACET
LISTED
NASDAQ
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
News Preview
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on November 28, 2025.
One individual was hired by Adicet in November 2025 and granted new hire non-qualified stock options to...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.11.2025
NAYA
LISTED
NASDAQ
INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”
News Preview
Acquisition advances INVO’s national expansion strategy, enhances its clinical capabilities, and broadens access to innovative fertility care across the Midwest Acquisition advances INVO’s national expansion strategy, enhances its clinical capabilities, and broadens access to innovative fertility care across the Midwest...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.11.2025
METN
LISTED
SIX
Innovative Pyrolyse-Technologie ebnet Weg zur klimafreundlichen Industrieproduktion
News Preview
Metall Zug AG
/ Schlagwort(e): Nachhaltigkeit/ESG
Innovative Pyrolyse-Technologie ebnet Weg zur klimafreundlichen Industrieproduktion
28.11.2025 / 17:55 CET/CEST
Medienmitteilung
Zug, 28. November 2025 - Der 2022 gegründete «Verein zur Dekarbonisierung der Industrie» (VZDI) hat heute Nachmittag gemeinsam mit seinen Mitg......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.11.2025
METN
LISTED
SIX
Innovative pyrolysis technology paves the way for climate-friendly industrial production
News Preview
Metall Zug AG
/ Key word(s): Sustainability/ESG
Innovative pyrolysis technology paves the way for climate-friendly industrial production
28.11.2025 / 17:55 CET/CEST
Media announcement
Zug, November 28, 2025 – The «Association for the Decarbonization of Industry» (VZDI), founded in 2022, together with its members and Emp......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.11.2025
Q11
LISTED
XETRA
Viromed Medical AG and HELLMUT RUCK GmbH have concluded an exclusive distribution agreement for plasma devices
News Preview
Viromed Medical AG and HELLMUT RUCK GmbH have concluded an exclusive distribution agreement for plasma devices
Rellingen, November 28, 2025 – Viromed Medical AG, a specialist in medical technologies, and HELLMUT RUCK GmbH, a leading provider of podiatry, foot care, and cosmetic solutions, announce the conclusion of an exclusive partnership for Eur......
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2025
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Update statement regarding the re-election of two Directors at the 2025 Annual General Meeting (AGM)
News Preview
Worldwide Healthcare Trust PLC
Update Statement Regarding the Re-Election of Two Directors
at the 2025 Annual General Meeting (AGM)
All of the resolutions proposed at the Company's AGM on 9 July 2025 were passed comfor...
Themefolio
Profiler
Peergroup
© BusinessWire
28.11.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRA...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.11.2025
QNTM
LISTED
NASDAQ
REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
News Preview
TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), is pleased to announce that national television network CTV News’ flagship investigative program W5 has aired Part 2 of a three-part series about Quantum Biopharma and the company’s allegations of stock market manipulati...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.11.2025
KTTA
LISTED
NASDAQ
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
News Preview
MIAMI, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (“Pasithea” or the “Company”) (Nasdaq: KTTA; KTTAW), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic oral MEK inhibitor for the treatment of neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN), today announced the pricing...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2025
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.11.2025
PACB
LISTED
NASDAQ
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference
News Preview
MENLO PARK, Calif., Nov. 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at Piper Sandler’s 37th Annual Healthcare Conference on Wednesday, December 3, 2025, at 11:30 AM ET in New York, NY....
Themefolio
Profiler
Peergroup
© BusinessWire
28.11.2025
HHL
LISTED
TSX
Harvest ETFs Announces Estimated Annual 2025 Reinvested ETF Distributions
News Preview
Harvest Portfolios Group Inc. (“Harvest”) today announces the estimated annual reinvested distributions for Harvest ETFs for the 2025 tax year.
Please note these are estimated amounts only as of October 31, 2025 and could change due to events that occur between the date of these estimates and the date of the ETFs’ taxation year end. These events...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2025
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
News Preview
FDA requests, and Vanda agrees to, a brief extension (to December 5, 2025) for the expedited re-review of the partial clinical hold on long-term studiesSeparately, FDA recently issued labeling comments, and labeling discussions have formally begun for the New Drug Application of tradipitant for the prevention of vomiting induced by motion (PDUFA t...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.11.2025
SPRO
LISTED
NASDAQ
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CAMBRIDGE, Mass., Nov. 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that on November 3, 2025, the Compensation Committee of Spero’s Board...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.11.2025
TGTX
LISTED
NASDAQ
TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
News Preview
Fireside chat scheduled for Tuesday, December 2, 2025 at 12:30 PM ET Fireside chat scheduled for Tuesday, December 2, 2025 at 12:30 PM ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.11.2025
ABBV
LISTED
EURONEXT
SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance
News Preview
MONTREAL, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Today, AbbVie (NYSE: ABBV) has announced two positive updates for Canadians living with ulcerative colitis (UC)....
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2025
IDYA
LISTED
NASDAQ
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
SOUTH SAN FRANCISCO, Calif., Nov. 28, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on November 26, 2025, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to p...
Themefolio
Profiler
Peergroup
© Newsfile
28.11.2025
HBFG
LISTED
CSE
Happy Belly Food Group's Rosie's Burgers QSR Announces the Opening of Its First Atlantic Canada Location in Halifax, Nova Scotia
News Preview
Toronto, Ontario--(Newsfile Corp. - November 28, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands, is pleased to announce the grand opening of its first Atlantic Canada location for Rosie's Burgers ("Rosie's") in Halifax, Nova Scotia. The opening...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2025
1801
LISTED
HKSE
China's First Domestic IL-23p19 Monoclonal Antibody: Innovent's PECONDLE® (Picankibart Injection) Received NMPA Approval
News Preview
PECONDLE® (picankibart injection) has received approval from China's National Medical Products Administration (NMPA) for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systematic therapy.
PECONDLE® is the world's first IL-23p19 antibody whose registrational Phase 3 clinical trial met its primary end...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2025
SECT_B
LISTED
STO
Invitation to presentation of Sectra's six-month report 2025/2026
News Preview
LINKÖPING, Sweden, Nov. 28, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) invites investors, analysts, and the media to a presentation of the company's six-month report with President Torbjörn Kronander and CFO Jessica Holmquist.
Publication of the financial report: 8:15 a.m. (CET) on December...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
28.11.2025
FWBI
LISTED
NASDAQ
Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX"
News Preview
BOCA RATON, FL / ACCESS Newswire / November 28, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) (the "Company") today announced that it will change its name to GridAI Technologies Corp., effective at 12:01 Eastern Time on Monday, December 1, 2025. The name change closely aligns the Company's business following its acquisition of 100% of GR...
Themefolio
Profiler
Peergroup
© BusinessWire
28.11.2025
IPH
LISTED
EURONEXT
Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
News Preview
Regulatory News:
Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) releases its total number of shares outstanding as well...
Themefolio
Profiler
Peergroup
© PR Newswire
28.11.2025
IMU
LISTED
ASX
Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours
News Preview
Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytics (CF33-CD19) oncolytic virus and JW's CD19 CAR-T cell therapy, Carteyva®, in refractory solid tumors.The collaboration includes preclinical studies, followed by a Phase 1 investigator-initiated t...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.11.2025
9969
LISTED
HKSE
InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis
News Preview
InnoCare's pipeline under development now covers ten major autoimmune diseases, with a particular focus on dermatological conditions....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.11.2025
BIIB
LISTED
NASDAQ
Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan
News Preview
If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the initiation of treatment for this progressive, relentless disease If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the initiation of treatment for this progress...
Themefolio
Profiler
Peergroup
© BusinessWire
28.11.2025
DNTL
LISTED
TSX
Dentalcorp Announces that Leading Proxy Advisors ISS and Glass Lewis Recommend Dentalcorp Shareholders Vote “FOR” the Arrangement and Provides Update Regarding Partner Dentist Rollover Opportunity
News Preview
dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company”) (TSX: DNTL) announced today that leading independent proxy advisory firms Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis & Co. LLC (“Glass Lewis”) have each recommended that the Company’s shareholders vote FOR the special resolution (the “Arrangement Resolution”) to appr...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2025
NYXH
LISTED
NASDAQ
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
News Preview
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2025
QNTM
LISTED
NASDAQ
Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
News Preview
TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), is pleased to announce that national television network CTV News’ flagship investigative program W5 has aired Part 2 of a three-part series about Quantum Biopharma and the company’s allegations of stock market manipulati...
Themefolio
Profiler
Peergroup
© Newsfile
27.11.2025
MUSL
LISTED
CSE
Promino Nutritional Sciences Inc. Announces Revocation of Cease Trade Order
News Preview
Burlington, Ontario--(Newsfile Corp. - November 27, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) (the "Company" or "Promino") is pleased to announce the full revocation of a Failure-to-File Cease Trade Order (the "FFCTO") issued by the Ontario Securities Commission (the "OSC") effective on November 26, 2025. The...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2025
GNFT
LISTED
EURONEXT
GENFIT Announces Appointment of new Chief Medical Officer
News Preview
GENFIT today announced the appointment of Dr. Pejvack Motlagh, the new Chief Medical Officer of GENFIT...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2025
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions erfüllt regulatorische Anforderungen hinsichtlich Nitrosaminverunreinigungen
News Preview
Piramal Pharma Solutions hat einen robusten Aktionsplan umgesetzt, um den sich wandelnden regulatorischen Anforderungen hinsichtlich Nitrosaminverunreinigungen gerecht zu werden. Durch umfassende Risikobewertungen, Bestätigungstests und Kontrollstrategien gewährleistet das Unternehmen die Sicherheit und Konformität seiner Arzneimittelwirkstoffe un...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2025
VENI
LISTED
CSE
Canadian Investment Regulatory Organization Trade Resumption - VENI
News Preview
VANCOUVER, BC, Nov. 27, 2025 /CNW/ - Trading resumes in:
Company: Vencanna Ventures Inc.CSE Symbol: VENI All Issues: YesResumption (ET): 10:45 amCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the natio...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2025
VENI
LISTED
CSE
Canadian Investment Regulatory Organization Trading Halt - VENI
News Preview
VANCOUVER, BC, Nov. 27, 2025 /CNW/ - The following issues have been halted by CIRO:
Company: Vencanna Ventures Inc.CSE Symbol: VENIAll Issues: YesReason: DisseminationHalt Time (ET): 9:44 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2025
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2025
LEGN
LISTED
NASDAQ
Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade
News Preview
Recognizes the company’s continued investment and expansion of cell therapy manufacturing and R&D operations in Ghent, reinforcing Flanders’ position as a global biotech hub...
Themefolio
Profiler
Peergroup
© Newsfile
27.11.2025
PSYC
LISTED
CSE
Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm
News Preview
Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of dietary supplements derived from the Amanita Muscaria mushroom, is pleased to announce the launch of Calmer, a new product offer...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2025
SAN
LISTED
EURONEXT
Communiqué de presse : Sanofi investit 50 millions d’euros au Trait pour accélérer la production de médicaments innovants
News Preview
Sanofi investit 50 millions d’euros au Trait pour accélérer la production de médicaments innovants...
Themefolio
Profiler
Peergroup
© Newsfile
27.11.2025
PER
LISTED
ASX
Edison Issues Report on Percheron Therapeutics (PER)
News Preview
London, United Kingdom--(Newsfile Corp. - November 27, 2025) - Edison issues report on Percheron Therapeutics (ASX: PER)We have refreshed our investment case for Percheron as the company heads into CY26 with a clearly defined Phase II plan for HMBD-002, backed by positive Phase I data and a strengthened management team. Our model now reflects the l...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2025
INNO
LISTED
CSE
Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M
News Preview
HERZLIYA, Israel and CALGARY, AB, Nov. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce its financial consolidated results for the nine months ended S...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2025
INNO
LISTED
CSE
Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M
News Preview
HERZLIYA, Israel and CALGARY, AB, Nov. 27, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce its financial consolidated results for the nine months ended Septembe...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2025
ORNBV
LISTED
HEL
71,498 Orion Corporation A shares converted into B shares
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 27 NOVEMBER 2025 at 9.00 EET ...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2025
340450
LISTED
KOE
GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology
News Preview
YONGIN, South Korea, Nov. 27, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its collaborative study with Professor Byeon, Jeong-Sik's team at Asan Medical Center has been published in The American Journal of Gastroenterology(AJG)....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.11.2025
PTGX
LISTED
NASDAQ
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice
News Preview
NEW YORK, NY / ACCESS Newswire / November 27, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) (the "Company") today announced that it has received a notification letter from the Nasdaq Listing Qualifications Staff (the "Staff") indicating that the Company is not in compliance with Nasdaq Listing Rules 5550(b)(1) (minimum stoc...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2025
326030
LISTED
KOE
SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation
News Preview
New addition strengthens SK Biopharmaceuticals' radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partnerships and value chain integrationSEOUL, South Korea, Nov. 26, 2025 /PRNewswire/ -- SK Biopharmaceuticals, CO., Ltd., a biotech company specializing in research, development, and commercialization of tr...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2025
NUZ
LISTED
ASX
Elanco executive appointed as Neurizon's Board Observer
News Preview
MELBOURNE, Australia, Nov. 26, 2025 /PRNewswire/ -- Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce the appointment of Ms Justine Conway as a Board Observer. Ms Conw...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2025
NUZ
LISTED
ASX
Elanco executive appointed as Neurizon's Board Observer
News Preview
MELBOURNE, Australia, Nov. 26, 2025 /PRNewswire/ -- Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce the appointment of Ms Justine Conway as a Board Observer. Ms Conw...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2025
13
LISTED
HKSE
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
News Preview
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the European Society for Medical Oncology (“ESMO”) Asia Congress 2025, taking pla...
Themefolio
Profiler
Peergroup
© Newsfile
26.11.2025
MYTC
LISTED
CSE
MyndTec Inc. Announces Resignation of Director
News Preview
Mississauga, Ontario--(Newsfile Corp. - November 26, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, today announced that P. Harvey Griggs has resigned from the Company's Board of Directors, effective November 26, 2025, for personal reasons to focus on his h...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
